CLGN News and Press, CollPlant Holdings Ltd.

CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler PR Newswire Intellectual Property Rights Secured in One of the Largest Target Markets for CollPlant's Product   Candidate REHOVOT, Israel , Feb. 26, 2026 /PRN...

CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex PR Newswire BioFlex Enables Rapid Formulation of Tunable rhCollagen Bioinks with Enhanced Tissue-Mimetic Performance BioFlex Expands CollPlant's Animal-Free Bioink Platform for Bioph...

CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments PR Newswire Next-generation rhCollagen-based technology aims to restore facial structure and skin quality in patients experiencing volume depletion linked to GLP-1 weight-loss therapies REHOVOT, Isra...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.4% to $2.24 on volume of 985,008,025 shares ProShares UltraShort Silver -2x Shares (ZSL) rose 39.0% to $2.92 on volume of 350,275,447 shares Jet.AI Inc. (JTAI) fell 5.4% to $0.14...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 0.8% to $2.2113 on volume of 905,825,928 shares ProShares UltraShort Silver -2x Shares (ZSL) rose 34.8% to $2.83 on volume of 297,953,845 shares Jet.AI Inc. (JTAI) fell 4.6% to $0....

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING PR Newswire REHOVOT, Israel , Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products base...

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire Expansion of rhCollagen and BioInk raw material sales in North American territories expected through a new partnership with a U.S.-based logistics center scheduled...

SUPER HI INTERNATIONAL HOLDING LTD. (HDL) is expected to report $0.2 for Q3 2025 Argo Blockchain plc (ARBK) is expected to report $-0.1 for Q3 2025 Banco Macro S.A. ADR (representing Ten Class B) (BMA) is expected to report $0.67 for Q3 2025 Adaptimmune Therapeutics plc (ADAPY) is exp...

CollPlant Biotechnologies Ltd. (CLGN) is expected to report $0.38 for Q3 2025

2025-11-25 17:41:44 ET CollPlant Biotechnologies Ltd. (CLGN) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 9.12%. The average open to low on the day of earnings was -8.90%. The average...